 | Up a level |
Sacco, R; Disanto, G; Maraffi, I; Candrian, U; Kamm, Christian Philipp; Rossi, S; Schwegler, G; Gallo, A; Gobbi, C; Zecca, C (2020). Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period? Multiple Sclerosis and Related Disorders, 38, p. 101523. Elsevier 10.1016/j.msard.2019.101523
Fluri, F; Hatz, F; Rutgers, M P; Georgiadis, D; Sekoranja, L; Schwegler, G; Sarikaya, H; Weder, B; Müller, F; Lüthy, R; Arnold, M; Reichhart, M; Mattle, H P; Tettenborn, B; Nedeltchev, K; Hungerbühler, H J; Sztajzel, R; Baumgartner, R W; Michel, P; Lyrer, P A; ... (2010). Intravenous thrombolysis in patients with stroke attributable to small artery occlusion. European journal of neurology, 17(8), pp. 1054-60. Oxford: Blackwell Science 10.1111/j.1468-1331.2010.02961.x
Meinel, T; Branca, M.; Nedeltchev, K; Bonati, L; Arnold, M.; Carrera, E; Michel, P; Cereda, C; Bolognese, M; Kägi, G; Luft, A; Backhaus, R; Salmen, S; Sturzenegger, R; Medlin, F; Berge, C; Schelosky, L; Renaud, S; Niederhauser, J; Bonvin, C; ... (7 November 2020). Stroke severity, acute recanalization therapies and 3-month outcomes among patients with atrial fibrillation accoring to preceding anticoagulation treatment - data from the Swiss Stroke Registry. International journal of stroke, 15(1S), p. 39. SAGE
